| Aptus Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | |||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 5.00 | 0.30 | 0.30 | ||
| Reserves | 1.97 | 1.47 | 0.67 | ||
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | ||
| Equity Application Money | 0.00 | 0.00 | 0.00 | ||
| Total Shareholders Funds | 6.97 | 1.77 | 0.97 | ||
| Secured Loans | 6.99 | 1.58 | 0.33 | ||
| Unsecured Loans | 3.36 | 3.73 | 1.89 | ||
| Total Debt | 10.35 | 5.31 | 2.22 | ||
| Other Liabilities | 0.25 | 0.17 | 0.11 | ||
| Total Liabilities | 17.57 | 7.25 | 3.30 | ||
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1.86 | 1.24 | 0.91 | ||
| Less: Accumulated Depreciation | 0.87 | 0.60 | 0.39 | ||
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | ||
| Net Block | 0.99 | 0.64 | 0.52 | ||
| Lease Adjustments | 0.00 | 0.00 | 0.00 | ||
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | ||
| Investments | 0.00 | 0.00 | 0.00 | ||
| Current Assets, Loans & Advances | |||||
| Inventories | 7.06 | 3.43 | 2.30 | ||
| Sundry Debtors | 5.64 | 3.35 | 2.40 | ||
| Cash and Bank Balance | 5.21 | 0.91 | 0.54 | ||
| Loans and Advances | 1.83 | 0.62 | 0.41 | ||
| Total Current Assets | 19.74 | 8.32 | 5.65 | ||
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 3.18 | 2.42 | 2.79 | ||
| Provisions | 1.17 | 0.36 | 0.14 | ||
| Total CL & Provisions | 4.35 | 2.79 | 2.92 | ||
| Net Current Assets | 15.39 | 5.53 | 2.72 | ||
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Assets | 0.07 | 0.06 | 0.04 | ||
| Deferred Tax Liability | 0.00 | 0.00 | 0.00 | ||
| Net Deferred Tax | 0.07 | 0.06 | 0.04 | ||
| Other Assets | 1.12 | 1.02 | 0.01 | ||
| Total Assets | 17.57 | 7.24 | 3.29 | ||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 |